Brexit Trade Deal Must Wait, But UK Medtech Sector Finds Reasons To Be Cheerful

During the week of the ostensibly pivotal EU Summit on Brexit, the UK government has made the EU27 wait for its white paper on proposed post-EU trading arrangements. The UK medtech industry, in turn, is kept waiting on its EU future. But far from remaining idle, manufacturers are focusing on innovation adoption and working with the NHS, where there is a new sense of purpose, and maybe a light at the end of the tunnel.

Brexit effect and global business consequences concept with Union Jack, EU flag on balls and world map globe 3D illustration.

No news is not always good news, but the medtech sector has become accustomed to the UK government's lack of guidance on the continuity of regulation and trade after the UK leaves the EU next March. And what of the proposed transition period to December 2020? The value of that to the medtech industry – in and beyond the UK – is still not clear.

The latest EU summit, on June 27-28, includes an EU27 roundtable to review the state of play and progress of the Brexit negotiations. It will focus on UK withdrawal issues...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe